Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Environ Toxicol Pharmacol ; 50: 167-174, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28214749

RESUMEN

Many chemicals have been used to increase the safety of consumer products by reducing their flammability and risk for ignition. Recent focus on brominated flame retardants, such as polybrominated diphenyl ethers (PBDEs) has shown them to contribute to neurobehavioral deficits in children, including learning and memory. As the manufacture and use of PBDEs have been reduced, replacement chemicals, such as hexabromocyclododecane (HBCDD) have been substituted. Our current study evaluated the neurotoxicity of HBCDD, concentrating on dopaminergic innervation to the hippocampus. Using an in vivo model, we exposed male mice to HBCDD and then assessed alterations to the dopamine synapse 6 weeks later. These exposures elicited significant reductions in presynaptic dopaminergic proteins, including TH, COMT, MAO-B, DAT, VMAT2, and alpha-synuclein. In contrast, postsynaptic dopamine receptors were not impaired. These findings suggest that the mesohippocampal dopamine circuit is vulnerable to HBCDD and the dopamine terminal may be a selective target for alteration.


Asunto(s)
Neuronas Dopaminérgicas/efectos de los fármacos , Retardadores de Llama/toxicidad , Hipocampo/efectos de los fármacos , Hidrocarburos Bromados/toxicidad , Animales , Regulación de la Expresión Génica/efectos de los fármacos , Hipocampo/citología , Masculino , Ratones , Transducción de Señal/efectos de los fármacos , Potenciales Sinápticos/efectos de los fármacos , alfa-Sinucleína/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA